Oncología Médica Traslacional y Terapia Individualizada del Cáncer

Taboada AGM; Lominchar PL; Martínez MF; García-Alfonso P; Martin AM; Asencio JM.

Neoadjuvant therapy impact in early pancreatic cancer: "bioborderline" vs. "non-bioborderline".

Annals Of Hepato-Biliary-Pancreatic Surgery. 2022; 26(4): 363-374 Nº de citas: 1 [doi:10.14701/ahbps.22-023]

Villanueva-Bueno C; Collado-Borrell R; Escudero-Vilaplana V; Revuelta-Herrero JL; Marzal-Alfaro MB; González-Haba E; Arranz-Arija JÁ; Osorio S; Herranz-Alonso A; Sanjurjo-Saez M.

A smartphone app to improve the safety of patients undergoing treatment with oral antineoplastic agents: 4 years of experience in a university hospital.

Frontiers in Public Health. 2022; 10: 978783-978783 Nº de citas: 3 [doi:10.3389/fpubh.2022.978783]

García Adrián S; Gonzalez, AR; De Castro, EM; Olmos, VP; Moran, LO; del Prado, PM; Fernandez, MS; Burón JDC; Escobar, IG; Galan, JM; Pérez AIF; Neria, F; Lavin, DC; Hernández BLSV; Jimenez-Fonseca, P; Muñoz Martín AJ.

Incidence, risk factors, and evolution of venous thromboembolic events in patients diagnosed with pancreatic carcinoma and treated with chemotherapy on an outpatient basis

EUROPEAN JOURNAL OF INTERNAL MEDICINE. 2022; 105: 30-37 Nº de citas: 10 [doi:10.1016/j.ejim.2022.07.020]

Quinaglia T; Gongora C; Awadalla M; Hassan MZO; Zafar A; Drobni ZD; Mahmood SS; Zhang L; Coelho-Filho OR; Suero-Abreu GA; Rizvi MA; Sahni G; Mandawat A; Zatarain-Nicolás E; Mahmoudi M; Sullivan R; Ganatra S; Heinzerling LM; Thuny F; Ederhy S; Gilman HK; Sama S; Nikolaidou S; Mansilla AG; Calles A; Cabral M; Fernández-Avilés F; Gavira JJ; González NS; García de Yébenes Castro M; Barac A; Afilalo J; Zlotoff DA; Zubiri L; Reynolds KL; Devereux R; Hung J; Picard MH; Yang EH; Gupta D; Michel C; Lyon AR; Chen CL; Nohria A; Fradley MG; Thavendiranathan P; Neilan TG.

Global Circumferential and Radial Strain Among Patients With Immune Checkpoint Inhibitor Myocarditis

JACC-Cardiovascular Imaging. 2022; 15(11): 1883-1896 Nº de citas: 23 [doi:10.1016/j.jcmg.2022.06.014]

de la Rosa, CA; Castellanos, PC; Lazaro-Quintela, M; Domine, M; Estevez, SV; Lopez-Vivanco, G; Perez, JLF; Romero, JLA; Delgado, LF; Giron, CG; Tain, PD; Alvarez, RA; Sanchis, PM; Canton, IF; Abos, IM; Aguillo, MM; Gutierrez, LGA; Granados, ALO; Cabellos, RA; Sebastian, AG; Sifuentes, LFG; Reguart, N.

Identification of ALK-positive patients with advanced NSCLC and real-world clinical experience with crizotinib in Spain (IDEALK study)

LUNG CANCER. 2022; 173: 83-93 Nº de citas: 7 [doi:10.1016/j.lungcan.2022.09.010]

Climent, MA; Font, A; Duran, I; Puente, J; Mendez-Vidal, MJ; Saez, MI; Lobera, CS; Arija, JAA; Gonzalez-Del-Alba, A; Sanchez-Hernandez, A; Fita, MJJ; Esteban, E; Alonso-Gordoa, T; Gonzalez, BM; Maroto, P; Lazaro-Quintela, M; Cassinello-Espinosa, J; Perez-Valderrama, B; Garcias, C; Castellano, D.

A phase II randomised trial of abiraterone acetate plus prednisone in combination with docetaxel or docetaxel plus prednisone after disease progression to abiraterone acetate plus prednisone in patients with metastatic castration-resistant prostate cancer: The ABIDO-SOGUG trial

EUROPEAN JOURNAL OF CANCER. 2022; 175: 110-119 Nº de citas: 9 [doi:10.1016/j.ejca.2022.08.002]

Vera, R; Ibarrola-de-Andres, C; Adeva, J; Perez-Rojas, J; Garcia-Alfonso, P; Rodriguez-Gil, Y; Macarulla, T; Serrano-Pinol, T; Mondejar, R; Madrigal-Rubiales, B.

Expert consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the determination of biomarkers in pancreatic and biliary tract cancer

CLINICAL & TRANSLATIONAL ONCOLOGY. 2022; 24(11): 2107-2119 Nº de citas: 3 [doi:10.1007/s12094-022-02873-0]

Lope, V; Guerrero-Zotano, A; Ruiz-Moreno, E; Bermejo, B; Antolin, S; Montano, A; Baena-Canada, JM; Vazquez, MR; de Larrea-Baz, NF; Chacon, JI; Garcia-Saenz, JA; Olier, C; Munoz, M; Anton, A; Rovira, PS; Lanza, AA; Gonzalez, S; Oltra, A; Brunet, J; Gregori, JG; Martinez, MT; Calvo, L; Rosell, L; Bezares, S; Pastor-Barriuso, R; Perez-Gomez, B; Martin, M; Pollan, M.

Clinical and Sociodemographic Determinants of Adherence to World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) Recommendations in Breast Cancer Survivors-Health-EpiGEICAM Study

Cancers. 2022; 14(19): Nº de citas: 9 [doi:10.3390/cancers14194705]

Carmona-Bayonas, A; Verso, M; Canovas, MS; Perez, JR; de Herreros, MG; del Prado, PM; Perez, IF; Verduguez, TQ; Portero, BO; Olmos, VP; Gomez, D; Ortega, L; Moyano, MS; Brozos, EM; Biosca, M; Rebollo, MA; Sanchez, LT; Perez, CH; Buron, JDC; Lago, NM; Perez, EG; Langa, JM; Segura, PP; de Castro, EM; Jimenez-Fonseca, P; Agnelli, G; Munoz, A.

Do Antiangiogenics Promote Clot Instability? Data from the TESEO Prospective Registry and Caravaggio Clinical Trial

THROMBOSIS AND HAEMOSTASIS. 2022; 122(10): 1653-1661 Nº de citas: 2 [doi:10.1055/a-1816-8347]

Canovas, MS; Garay, DF; Moran, LO; Perez, JR; Rubio, CMG; de Mena, ML; Portero, BO; Castro, JB; Lage, Y; Lavin, DC; Blanco, ABR; de Soignie, AMMF; Perejon, JZB; Colomo, LJ; Boluda, NB; Moreno, JB; Verduguez, TQ; Garrido, CR; Huertas, RM; Puig, CFI; Martin, AJM.

Immune checkpoint inhibitors-associated thrombosis in patients with lung cancer and melanoma: a study of the Spanish society of medical oncology (SEOM) thrombosis and cancer group

CLINICAL & TRANSLATIONAL ONCOLOGY. 2022; 24(10): 2010-2020 Nº de citas: 11 [doi:10.1007/s12094-022-02860-5]

Majem, M; Alvarez, R; Ortega, AL; de Alda, LR; Gordo, R; Garcia, JF; Ivanova-Markova, Y; Gonzalez-Dominguez, A; San Cristobal, RS; Rojo, F.

Cost-benefit analysis of ALK diagnosis vs. non-diagnosis in patients with advanced non-small cell lung cancer in Spain

GLOBAL & REGIONAL HEALTH TECHNOLOGY ASSESSMENT. 2022; 9: 82-90 Nº de citas: 2 [doi:10.33393/grhta.2022.2449]

Galactionova, K; Loibl, S; Salari, P; Marme, F; Martin, M; Untch, M; Bonnefoi, HR; Kim, SB; Bear, HD; McCarthy, N; Gelmon, KA; Garcia-Saenz, JA; Kelly, CM; Reimer, T; Toi, M; Rugo, HS; Gnant, M; Makris, A; Burchardi, N; Schwenkglenks, M.

Cost-effectiveness of palbociclib in early breast cancer patients with a high risk of relapse: Results from the PENELOPE-B trial

Frontiers in Oncology. 2022; 12: Nº de citas: 3 [doi:10.3389/fonc.2022.886831]

Larkin J; Weber J; Del Vecchio M; Gogas H; Arance AM; Dalle S; Cowey CL; Schenker M; Grob JJ; Chiarion-Sileni V; Márquez-Rodas I; Butler MO; Di Giacomo AM; Middleton MR; De la Cruz-Merino L; Arenberger P; Atkinson V; Hill A; Fecher LA; Millward M; Khushalani NI; Queirolo P; Long GV; Lobo M; Askelson M; Ascierto PA; Mandalá M.

Adjuvant nivolumab versus ipilimumab (CheckMate 238 trial): Reassessment of 4-year efficacy outcomes in patients with stage III melanoma per AJCC-8 staging criteria

EUROPEAN JOURNAL OF CANCER. 2022; 173: 285-296 Nº de citas: 24 [doi:10.1016/j.ejca.2022.06.041]

Vazquez, JC; Pinero, A; de Castro, FJ; Lluch, A; Martin, M; Barnadas, A; Alba, E; Rodriguez-Lescure, A; Rojo, F; Gimenez, J; Sola, I; Quintana, MJ; Bonfill, X; Urrutia, G; Sanchez-Rovira, P.

The value of sentinel lymph-node biopsy after neoadjuvant therapy: an overview

CLINICAL & TRANSLATIONAL ONCOLOGY. 2022; 24(9): 1744-1754 Nº de citas: 6 [doi:10.1007/s12094-022-02824-9]

Donat-Vargas, C; Guerrero-Zotano, A; Lope, V; Bermejo, B; Casas, A; Baena-Canada, JM; Antolin, S; Sanchez-Rovira, P; Anton, A; Garcia-Saenz, JA; Ramos, M; Munoz, M; de Juan, A; Sanchez, CJ; Chacon, JI; Gil-Gil, M; Conejero, RA; Llombart, A; Bezares, S; de Larrea-Baz, NF; Perez-Gomez, B; Martin, M; Pollan, M.

Type does matter. Use VIRGIN olive oil as your preferred fat to reduce your risk of breast cancer: case-control EpiGEICAM study

EUROPEAN JOURNAL OF CLINICAL NUTRITION. 2022; 76(9): 1343-1346 Nº de citas: 2 [doi:10.1038/s41430-022-01101-w]

Zhu, Z; Turner, NC; Loi, S; Andre, F; Martin, M; Dieras, V; Gelmon, KA; Harbeck, N; Zhang, C; Cao, JQ; Yan, ZM; Lu, DR; Wei, P; VanArsdale, TL; Rejto, PA; Huang, X; Rugo, HS; Loibl, S; Cristofanilli, M; Finn, RS; Liu, Y.

Comparative biomarker analysis of PALOMA-2/3 trials for palbociclib

npj Precision Oncology. 2022; 6(1): Nº de citas: 5 [doi:10.1038/s41698-022-00297-1]

Martin-Roman, L; Fernandez-Martinez, M; Kayser Mata, S; Colombari, R; Pascual-Espinosa, P; Rey-Valcarcel, C; Jimenez-Gomez, LM; Turegano-Fuentes, F.

Relevance of pneumoperitoneum in the conservative approach to complicated acute diverticulitis A retrospective study identifying risk factors associated with treatment failure

Minerva Surgery. 2022; 77(4): 327-334 Nº de citas: 4 [doi:10.23736/S2724-5691.21.08997-8]

Wysocki, O; Zhou, C; Rogado, J; Huddar, P; Shotton, R; Tivey, A; Albiges, L; Angelakas, A; Arnold, D; Aung, T; Banfill, K; Baxter, M; Barlesi, F; Bayle, A; Besse, B; Bhogal, T; Boyce, H; Britton, F; Calles, A; Castelo-Branco, L; Copson, E; Croitoru, A; Dani, SS; Dickens, E; Eastlake, L; Fitzpatrick, P; Foulon, S; Frederiksen, H; Ganatra, S; Gennatas, S; Glenthoj, A; Gomes, F; Graham, DM; Hague, C; Harrington, K; Harrison, M; Horsley, L; Hoskins, R; Hudson, Z; Jakobsen, LH; Joharatnam-Hogan, N; Khan, S; Khan, UT; Khan, K; Lewis, A; Massard, C; Maynard, A; McKenzie, H; Michielin, O; Mosenthal, AC; Obispo, B; Palmieri, C; Patel, R; Pentheroudakis, G; Peters, S; Rieger-Christ, K; Robinson, T; Romano, E; Rowe, M; Sekacheva, M; Sheehan, R; Stockdale, A; Thomas, A; Turtle, L; Vinal, D; Weaver, J; Williams, S; Wilson, C; Dive, C; Landers, D; Cooksley, T; Freitas, A; Armstrong, AC; Lee, RJ.

An International Comparison of Presentation, Outcomes and CORONET Predictive Score Performance in Patients with Cancer Presenting with COVID-19 across Different Pandemic Waves

Cancers. 2022; 14(16): Nº de citas: 2 [doi:10.3390/cancers14163931]